BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mercury Therapeutics, Inc. 

2E Gill Street

Woburn  Massachusetts  01801  U.S.A.
Phone: 781-932-1125 Fax: 781-935-8140


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
AMPK Activator Licensing Deal Highlights Successful Collaboration Between Boston-based Mercury Therapeutics, Inc. and CreaGen Biosciences 10/27/2009 9:29:12 AM
Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930 A First-in-Class, Small Molecule Activator of AMPK for Treatment of Type 2 Diabetes 8/4/2009 9:31:43 AM
Mercury Therapeutics, Inc. Outlicenses Research Products Applications of AMP-Activated Protein Kinase to Millipore Corporation (MIL) 5/19/2009 11:19:39 AM
Mercury Therapeutics, Inc. Patents Filed Patents Filed on Lead Compounds That Directly and Specifically Activate AMPK 3/31/2008 10:59:38 AM
Mercury Therapeutics, Inc. Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences, Inc. 3/12/2008 10:49:13 AM
Mercury Therapeutics, Inc. Breakthrough for Patients With Type-2 Diabetes 11/26/2007 8:37:59 AM